RECENT progress in glucagon research has made this hormone available in high purity, clarified its important role in carbohydrate metabolism and suggested its applicability in many clinical problems.

Glucagon is underused for treating severe hypoglycemia in both emergency and outpatient settings, new research suggests. Findings from an analysis of data on glucagon administration by emergency ...

Eighteen hospitalized male diabetic patients, thirty to sixty-nine years of age, were studied. The known duration of the diabetes in the group ranged from one to twenty-five years. All patients ...

Please provide your email address to receive an email when new articles are posted on . Children with type 1 diabetes who experienced a moderate hypoglycemic event returned to euglycemic status within ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio New data demonstrate glucagon ...

(HealthDay News) – Glucagon increases satiety index in lean individuals and in individuals with type 1 diabetes mellitus (T1DM), but not in those with obesity, according to a study published online ...

Austin, TX's Xeris Pharmaceuticals wrapped up a $41 million Series C financing round, as it heads toward approval (or rejection) of its diabetes injection pen for the administration of glucagon, a ...

New York, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Glucagon-like Peptide 1 Market: Analysis By Product, By Route ...